Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. System Of Radiation Protection Overview‏‎ (43 revisions)
  6. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  10. Information for healthcare providers (old)‏‎ (24 revisions)
  11. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  12. Radon For Governments and Employers‏‎ (23 revisions)
  13. Effective dose‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. ICRP publications‏‎ (14 revisions)
  20. System of radiation protection module 2‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Objectives of Radiological Protection‏‎ (9 revisions)
  25. Air-kerma rate constant‏‎ (9 revisions)
  26. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  27. Absorbed dose‏‎ (9 revisions)
  28. Effects of Exposure‏‎ (8 revisions)
  29. Prudence‏‎ (8 revisions)
  30. Beneficence‏‎ (8 revisions)
  31. Organ/tissue absorbed dose‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. Exposure Categories and Situations‏‎ (6 revisions)
  34. Investigation level‏‎ (6 revisions)
  35. Alimentary tract‏‎ (6 revisions)
  36. ICRPædia Guides‏‎ (6 revisions)
  37. Justice‏‎ (6 revisions)
  38. Linear energy transfer‏‎ (6 revisions)
  39. Accelerated fractionation‏‎ (6 revisions)
  40. Radiation weighting factor‏‎ (5 revisions)
  41. Air-kerma, entrance surface‏‎ (5 revisions)
  42. Sources of Radiation Exposure‏‎ (5 revisions)
  43. Dose coefficient‏‎ (5 revisions)
  44. Quality factor‏‎ (5 revisions)
  45. Principle of optimisation‏‎ (5 revisions)
  46. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  47. Absorbed fraction‏‎ (5 revisions)
  48. Justification‏‎ (5 revisions)
  49. Kerma‏‎ (5 revisions)
  50. Protection quantities‏‎ (5 revisions)
  51. Types of materials‏‎ (5 revisions)
  52. Reference Animal and Plant‏‎ (4 revisions)
  53. Kp index‏‎ (4 revisions)
  54. Protective action‏‎ (4 revisions)
  55. Source-related assessment‏‎ (4 revisions)
  56. Forbiddenness‏‎ (4 revisions)
  57. Aerodynamic diameter‏‎ (4 revisions)
  58. ICRP‏‎ (4 revisions)
  59. Reference bioassay function‏‎ (4 revisions)
  60. Diagnostic reference level‏‎ (4 revisions)
  61. Risk‏‎ (4 revisions)
  62. Senescence‏‎ (4 revisions)
  63. Air-kerma, product‏‎ (4 revisions)
  64. Fractionation sensitivity‏‎ (4 revisions)
  65. Optimisation‏‎ (4 revisions)
  66. Sievert‏‎ (4 revisions)
  67. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  68. S coefficient (radiation weighted)‏‎ (4 revisions)
  69. Non-maleficence‏‎ (4 revisions)
  70. High linear energy transfer radiation‏‎ (4 revisions)
  71. Direct bioassay‏‎ (4 revisions - redirect page)
  72. Bioassay‏‎ (4 revisions)
  73. Calculating Radon Doses‏‎ (4 revisions)
  74. Computed tomography dose index‏‎ (4 revisions)
  75. Mass median diameter‏‎ (4 revisions)
  76. Alpha decay‏‎ (4 revisions)
  77. Effective charge number‏‎ (4 revisions)
  78. Math‏‎ (4 revisions)
  79. Programmed cell death‏‎ (4 revisions)
  80. Effective half-life‏‎ (4 revisions)
  81. Averted dose‏‎ (4 revisions)
  82. DS02‏‎ (3 revisions)
  83. Fluoroscopically guided interventions‏‎ (3 revisions)
  84. Annual dose‏‎ (3 revisions)
  85. Potential exposure‏‎ (3 revisions)
  86. Rigidity threshold‏‎ (3 revisions)
  87. Dose of record (E)‏‎ (3 revisions)
  88. Low Earth orbit‏‎ (3 revisions)
  89. Accountability‏‎ (3 revisions)
  90. X ray‏‎ (3 revisions)
  91. Half-life, physical‏‎ (3 revisions)
  92. Cell death‏‎ (3 revisions)
  93. Contamination‏‎ (3 revisions)
  94. Exponential survival curve‏‎ (3 revisions)
  95. Unsealed source‏‎ (3 revisions)
  96. Xerostomia‏‎ (3 revisions)
  97. Annual limit on intake‏‎ (3 revisions)
  98. Dose per content function‏‎ (3 revisions)
  99. Interphase death‏‎ (3 revisions)
  100. Equity‏‎ (3 revisions)
  101. Test‏‎ (3 revisions)
  102. Graded approach‏‎ (3 revisions)
  103. Public exposure‏‎ (3 revisions)
  104. Fractionation‏‎ (3 revisions)
  105. Uptake‏‎ (3 revisions)
  106. Active (red) bone marrow‏‎ (3 revisions)
  107. Utilitarian ethics‏‎ (3 revisions)
  108. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  109. Operational quantity‏‎ (3 revisions)
  110. Value judgement‏‎ (3 revisions)
  111. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  112. Coster-Kronig transition‏‎ (3 revisions)
  113. Emergency preparedness‏‎ (3 revisions)
  114. Valvular heart disease‏‎ (3 revisions)
  115. Gray‏‎ (3 revisions)
  116. Personal dose equivalent‏‎ (3 revisions)
  117. Principle of justification‏‎ (3 revisions)
  118. Radiofrequency ablation‏‎ (3 revisions)
  119. Iso-effect plots‏‎ (3 revisions)
  120. Emergency procedures‏‎ (3 revisions)
  121. Lifetime risk estimates‏‎ (3 revisions)
  122. Absolute risk‏‎ (3 revisions)
  123. Virtue ethics‏‎ (3 revisions)
  124. Auger transition‏‎ (3 revisions)
  125. Bystander effect‏‎ (3 revisions)
  126. Derived air concentration‏‎ (3 revisions)
  127. Dignity‏‎ (3 revisions)
  128. Isomers‏‎ (3 revisions)
  129. Employer‏‎ (3 revisions)
  130. Activity median thermodynamic diameter‏‎ (3 revisions)
  131. Voxel phantom‏‎ (3 revisions)
  132. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  133. Complex tissues‏‎ (3 revisions)
  134. Growth fraction‏‎ (3 revisions)
  135. Organ dose equivalent‏‎ (3 revisions)
  136. Excretion rate (instantaneous)‏‎ (3 revisions)
  137. Extrathoracic airways‏‎ (3 revisions)
  138. Galactic cosmic radiation‏‎ (3 revisions)
  139. Growth hormone (somatotropin)‏‎ (3 revisions)
  140. ICRP Publication 103‏‎ (3 revisions)
  141. DNA damage signalling‏‎ (3 revisions)
  142. Spread-out Bragg peak‏‎ (3 revisions)
  143. Fairness‏‎ (3 revisions)
  144. Absorption‏‎ (3 revisions)
  145. Gamma ray‏‎ (3 revisions)
  146. Recovery‏‎ (3 revisions)
  147. Dose equivalent‏‎ (3 revisions)
  148. Field-size effect (Volume effect)‏‎ (3 revisions)
  149. Gastrointestinal syndrome‏‎ (3 revisions)
  150. Wisdom‏‎ (3 revisions)
  151. Biomedical research volunteer‏‎ (3 revisions)
  152. Cardiomyopathy‏‎ (3 revisions)
  153. Dose limit‏‎ (3 revisions)
  154. Target region‏‎ (3 revisions)
  155. Flexible tissues‏‎ (3 revisions)
  156. Guide to the System of Radiological Protection‏‎ (3 revisions)
  157. Autonomy‏‎ (3 revisions)
  158. Dose‏‎ (3 revisions)
  159. Dose limits‏‎ (3 revisions)
  160. Fluence‏‎ (3 revisions)
  161. Constancy test‏‎ (3 revisions)
  162. Rigidity‏‎ (2 revisions)
  163. Dose-length product‏‎ (2 revisions)
  164. Security‏‎ (2 revisions)
  165. Incident‏‎ (2 revisions)
  166. Intermediate level waste‏‎ (2 revisions)
  167. Stenosis‏‎ (2 revisions)
  168. Equieffective dose‏‎ (2 revisions)
  169. Local DRL‏‎ (2 revisions)
  170. Expanded and aligned radiation field‏‎ (2 revisions)
  171. Tolerability‏‎ (2 revisions)
  172. Medical exposure‏‎ (2 revisions)
  173. Naturally occurring radioactive material‏‎ (2 revisions)
  174. Adventitious‏‎ (2 revisions)
  175. Working level month‏‎ (2 revisions)
  176. Habitual nose breather‏‎ (2 revisions)
  177. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  178. Background dose (rate)‏‎ (2 revisions)
  179. Radiosensitivity, cellular‏‎ (2 revisions)
  180. Containment‏‎ (2 revisions)
  181. Detriment‏‎ (2 revisions)
  182. Dose-rate effect‏‎ (2 revisions)
  183. Inclusiveness‏‎ (2 revisions)
  184. Source-related‏‎ (2 revisions)
  185. Internal conversion electron‏‎ (2 revisions)
  186. Electron-capture decay‏‎ (2 revisions)
  187. LD 50/30‏‎ (2 revisions)
  188. Telangiectasia‏‎ (2 revisions)
  189. Member of the public‏‎ (2 revisions)
  190. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  191. Unattached fraction‏‎ (2 revisions)
  192. Necrosis‏‎ (2 revisions)
  193. Patient entrance reference point‏‎ (2 revisions)
  194. Hypoplasia‏‎ (2 revisions)
  195. Backscatter detection system‏‎ (2 revisions)
  196. Potential recoverability correction factor‏‎ (2 revisions)
  197. Bradycardia‏‎ (2 revisions)
  198. Protective action guide‏‎ (2 revisions)
  199. Radiation worker‏‎ (2 revisions)
  200. Reference air kerma‏‎ (2 revisions)
  201. Decay constant‏‎ (2 revisions)
  202. Self-help protection‏‎ (2 revisions)
  203. Individual-related‏‎ (2 revisions)
  204. Dose of record Hp (10)‏‎ (2 revisions)
  205. Electrophysiology‏‎ (2 revisions)
  206. Storage‏‎ (2 revisions)
  207. Track structure‏‎ (2 revisions)
  208. Mendelian diseases‏‎ (2 revisions)
  209. Accreditation‏‎ (2 revisions)
  210. Neurological syndrome‏‎ (2 revisions)
  211. Genomic integrity‏‎ (2 revisions)
  212. Occupational exposure‏‎ (2 revisions)
  213. Hazard‏‎ (2 revisions)
  214. Peak skin dose‏‎ (2 revisions)
  215. Bragg peak‏‎ (2 revisions)
  216. Radioactive dispersion device‏‎ (2 revisions)
  217. Radon: Units of Measure‏‎ (2 revisions)
  218. Coronary heart disease‏‎ (2 revisions)
  219. Decommissioning‏‎ (2 revisions)
  220. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  221. Dose-threshold‏‎ (2 revisions)
  222. Individual decontamination‏‎ (2 revisions)
  223. Subcutaneous tissue‏‎ (2 revisions)
  224. Low dose rate‏‎ (2 revisions)
  225. Transfer compartment‏‎ (2 revisions)
  226. Mitigation‏‎ (2 revisions)
  227. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  228. Action Level‏‎ (2 revisions)
  229. Upper reference levels‏‎ (2 revisions)
  230. Neurovascular syndrome‏‎ (2 revisions)
  231. Health Surveillance‏‎ (2 revisions)
  232. Pelagic‏‎ (2 revisions)
  233. Basal cell‏‎ (2 revisions)
  234. Practical radiological protection culture‏‎ (2 revisions)
  235. Branching fraction‏‎ (2 revisions)
  236. Chronic exposure‏‎ (2 revisions)
  237. Radioactive source‏‎ (2 revisions)
  238. Colony‏‎ (2 revisions)
  239. Cosmic Radiation in Aviation‏‎ (2 revisions)
  240. Reference biokinetic model‏‎ (2 revisions)
  241. Decontamination‏‎ (2 revisions)
  242. Relocation‏‎ (2 revisions)
  243. Diastasis‏‎ (2 revisions)
  244. Risk coefficient‏‎ (2 revisions)
  245. Individual monitoring‏‎ (2 revisions)
  246. Dose per unit intake coefficient‏‎ (2 revisions)
  247. Source term‏‎ (2 revisions)
  248. Emergency‏‎ (2 revisions)
  249. Latent time/period or latency interval‏‎ (2 revisions)
  250. Low level waste‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)